This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lam Research Corporation (LRCX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Lam Research (LRCX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Not the Best Time for the Semi Equipment Industry
by Sejuti Banerjea
While stocks like ASML and LRCX are good long-term bets on the Semiconductor Equipment - Wafer Fabrication industry, only ASML is likely to see continued growth this year.
Lam Research (LRCX) Q2 Earnings & Revenues Beat, Rise Y/Y
by Zacks Equity Research
Lam Research's (LRCX) fiscal second quarter results reflect strength across systems and the customer support business.
Mercury Systems (MRCY) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Along with increasing modernization in radar, electronic warfare and C4I, Mercury Systems' (MRCY) Q2 performance is likely to have been driven by revenue contributions from the newly acquired businesses.
Lam Research (LRCX) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Lam Research (LRCX) delivered earnings and revenue surprises of 7.64% and 3.87%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Stocks Stage Rally Despite Growing Recession Indicators
by Mayur Thaker
All eyes on Q4 '22 earnings over the next two weeks.
Factors Setting the Tone for Celestica (CLS) in Q4 Earnings
by Zacks Equity Research
Celestica's (CLS) Q4 earnings are likely to have benefited from strength in the ATS segment and the HPS business despite soft demand from OEM customers.
Jack Henry (JKHY) to Reduce Carbon Footprint With New Targets
by Zacks Equity Research
Jack Henry (JKHY) gears up to set science-based climate targets to achieve the long-term sustainability of its business model.
Will Supply-Chain Woes Dampen Roper's (ROP) Q4 Earnings?
by Zacks Equity Research
Supply-chain and cost woes are likely to have hurt Roper's (ROP) Q4 earnings, partly offset by strength across the Deltek, Vertafore and Aderant businesses within the Application Software unit.
Lam Research (LRCX) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Lam Research's (LRCX) second-quarter fiscal 2023 results are likely to gain from strong demand for semiconductor equipment. However, supply-chain constraints might have been a headwind.
Factors Likely to Decide CACI's Fate This Earnings Season
by Zacks Equity Research
CACI's Q2 results are likely to benefit from disciplined business development actions, consistent operational excellence and high customer satisfaction.
Investors Heavily Search Lam Research Corporation (LRCX): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Lam Research (LRCX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
F5 (FFIV) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
F5's (FFIV) Q1 performance is likely to have benefited from the hybrid work environment and the ongoing digital transformation wave, which is boosting the demand for secured communication networks.
What's in the Offing for Logitech (LOGI) in Q3 Earnings?
by Zacks Equity Research
The declining demand for PCs is likely to have hurt Logitech's (LOGI) peripheral sales in the third quarter of fiscal 2023.
Lam Research (LRCX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Lam Research (LRCX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lam Research (LRCX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $470.99, moving -0.57% from the previous trading session.
The Zacks Analyst Blog Highlights UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy
by Zacks Equity Research
UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy are part of the Zacks top analyst blog.
Top Research Reports for UnitedHealth Group, Coca-Cola & Roche Holding
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Coca-Cola Company (KO) and Roche Holding AG (RHHBY).
Progress Software (PRGS) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Progress Software's (PRGS) fourth-quarter fiscal 2022 results are likely to reflect gains from a strong portfolio that comprises Chef, OpenEdge, DataDirect and Sitefinity solutions.
Lam Research (LRCX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $464.30, moving +1.24% from the previous trading session.
Is a Beat Likely for Infosys (INFY) This Earnings Season?
by Zacks Equity Research
Infosys' (INFY) Q3 performance is likely to have been driven by the strong demand for the cloud, data analytics, the IoT, and security products and solutions amid the ongoing digital transformation wave.
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
TD SYNNEX (SNX) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Softened IT spending amid ongoing macroeconomic and geopolitical issues and unfavorable foreign currency exchange rates are likely to have hurt TD SYNNEX's (SNX) fourth-quarter performance.
Lam Research (LRCX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Lam Research (LRCX) closed the most recent trading day at $417.06, moving -1.28% from the previous trading session.
Why Lam Research (LRCX) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Lam Research (LRCX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.